Parkinson’s is a complex disorder. While there are many unknowns surrounding the disease, current research is aiming to understand disease mechanisms better and translate that into new treatments. Dr. Joohi Jimenez-Shahed of Baylor College of Medicine in Houston, TX discusses the state of Parkinson’s research and what that means for future treatments. She explains the importance of biomarkers in research, as well as their role in identifying Parkinson’s in the earlier stages of disease progression. She also shares an overview of treatments for the disease that do not necessarily involve dopamine. By modulating the dopamine system using different chemicals, complications from current Parkinson’s treatments may be minimized. Additionally, Dr. Jiminez-Shahed explains the efficacy of up-and-coming drugs for Parkinson’s treatment, many of which have promising results in clinical and animal trials.
How Parkinson’s disrupts neural networks and impacts how your body moves when you walk.
Meet our new Science Advisory Board members!
Dr. Drew walks us through the latest medications and interventions designed to help people live well with Parkinson’s.
Learn what you can do today to influence the future of Parkinson’s.
We are excited to announce the research we’ll be funding beginning in 2021: Removing Barriers to Deep Brain Stimulation Surgery…
This week, hundreds of Parkinson’s advocates are joining together for the Parkinson’s Policy Forum. On Thursday, March 25, many will…